Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
HR-LCMS/MS Reveals Astragalus dasyanthus as a Glabrol Source
2026-05-21
This study developed a streamlined HR-LCMS/MS-based workflow for rapid identification of autophagy-inducing compounds in plant extracts, using SH-SY5Y cells as an activity screen. The authors uncovered Astragalus dasyanthus as a novel source of the autophagy inducer glabrol, demonstrating an effective method for dereplication and high-throughput screening of bioactive phytochemicals.
-
Site-Specific Biotinylation of IL7 Preserves Bioactivity and
2026-05-21
This study presents a prokaryotic AviTag/BirA system enabling site-specific biotinylation of interleukin-7 (IL7), in contrast to conventional random chemical biotinylation that often impairs protein function. The approach minimizes activity loss, preserves antibody binding, and enhances the utility of biotin-IL7 in immunological and therapeutic applications.
-
SIS3 (Smad3 Inhibitor): Precision Tool for Fibrosis Research
2026-05-20
SIS3, a highly selective Smad3 inhibitor from APExBIO, enables targeted modulation of the TGF-β signaling pathway, supporting advanced fibrosis and osteoarthritis research. Its robust selectivity and validated in vitro and in vivo efficacy streamline experimental workflows and reveal new mechanistic insights.
-
CLCC1 Identified as Key Host Factor in Herpesvirus Nuclear E
2026-05-20
The referenced study uncovers CLCC1 as an essential host protein for the membrane fusion step of herpesvirus nuclear egress, revealing a previously unknown mechanism critical for viral replication. These findings provide a new cellular target for antiviral research and inform the development of immunomodulatory interventions.
-
Exemestane in Translational Breast Cancer: Mechanisms & Stra
2026-05-19
This thought-leadership article dissects exemestane’s molecular mechanism as a steroidal aromatase inhibitor and delivers strategic guidance for translational researchers. By integrating recent evidence, competitive landscape analysis, and hands-on workflow advice, we provide a roadmap for leveraging APExBIO’s exemestane in the evolving landscape of breast cancer research. The discussion bridges mechanistic insight with practical protocols and forward-looking perspectives, highlighting how this piece advances beyond conventional product content.
-
Senescence Genes as Diagnostic Signatures in Abdominal Aorti
2026-05-19
This study pioneers the identification of cellular senescence-associated genes, particularly ETS1 and ITPR3, as robust diagnostic biomarkers for abdominal aortic aneurysm (AAA). By integrating large-scale transcriptomic analyses with machine learning and multi-cohort validation, the research advances early detection strategies and offers insights for targeted therapeutic development.
-
Exemestane: Selective Steroidal Aromatase Inhibition in Rese
2026-05-18
Exemestane is a potent, selective, and irreversible steroidal aromatase inhibitor. It is widely employed for estrogen biosynthesis inhibition in breast cancer research. This article details its mechanism, evidence basis, and best practices for laboratory use.
-
IR-1061 Near Infrared Fluorescent Dye for Deep Tissue Imagin
2026-05-18
IR-1061 sets a new benchmark among near infrared fluorescent dyes by enabling high-clarity, deep tissue in vivo imaging with minimal background. Its unique photophysical properties, proven in advanced liposomal encapsulation protocols, empower synergistic imaging-therapy workflows that reimagine molecular imaging in biomedical research.
-
Nadolol (SQ-11725) in Advanced Cardiovascular Research Workf
2026-05-17
Unlock the experimental potential of Nadolol (SQ-11725) for hypertension, angina pectoris, and vascular headache research. This guide delivers actionable protocols, transporter-focused insights, and troubleshooting solutions—empowering labs to optimize beta-adrenergic signaling studies with APExBIO's rigorously validated compound.
-
3D DNA Frameworks Enhance Enzymatic Oligonucleotide Synthesi
2026-05-16
A recent study introduces tetrahedral DNA nanostructures (TDN) as organized scaffolds for enzymatic oligonucleotide synthesis (EOS), significantly improving enzyme accessibility and synthesis fidelity. This innovation enables longer, high-yield DNA synthesis with reduced errors, paving the way for advanced DNA data storage and genetic applications.
-
Angiotensin Peptides Facilitate SARS-CoV-2 Spike–AXL Binding
2026-05-15
Oliveira et al. (2025) reveal that naturally occurring angiotensin peptides, including truncated forms such as Angiotensin 1/2 (5-7), significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor, potentially influencing viral entry in host cells. These findings bridge renin-angiotensin system research with emerging questions in COVID-19 pathogenesis and highlight novel therapeutic targets.
-
Angiotensin 1/2 (5-7): Novel Insights for Cardiovascular and
2026-05-15
Explore the multifaceted research potential of Angiotensin 1/2 (5-7), a key peptide for RAS and hypertension studies. This article offers new perspectives on assay design, molecular mechanisms, and cross-domain implications for cardiovascular and SARS-CoV-2 research.
-
Optimizing Topotecan HCl Workflows as a Topoisomerase 1 Inhi
2026-05-14
Leverage Topotecan HCl for advanced, reproducible DNA damage and apoptosis induction in translational tumor models. This guide delivers stepwise workflow enhancements, troubleshooting strategies, and critical protocol parameters to maximize experimental success in antitumor research.
-
KU-55933: Potent ATM Kinase Inhibitor for DNA Damage Researc
2026-05-14
KU-55933 is a highly selective ATM kinase inhibitor with nanomolar potency, enabling precise interrogation of DNA damage response. This compound suppresses cancer cell proliferation and induces G1 cell cycle arrest, making it a tool of choice in cancer biology and genome stability research. APExBIO supplies KU-55933 (ATM Kinase Inhibitor, SKU A4605) for experimental use only.
-
Amorolfine Hydrochloride: Advanced Workflows for Fungal Rese
2026-05-13
Amorolfine Hydrochloride, a potent antifungal reagent, is transforming experimental workflows in fungal cell membrane and ploidy research. This article distills protocol enhancements, troubleshooting strategies, and actionable insights—bridging molecular mechanism with breakthrough applications for next-generation antifungal studies.